Ohio Pharmaceutical Lawyer and drug injury attorney Reviewing Testosterone Therapy Injury lawsuits and health complications for plaintiffs nationwide
The FDA is continuing to evaluate the data evaluating whether testosterone increases the risk of heart attack, stroke and death for men taking FDA-approved testosterone therapies.
Following several studies published in peer review journals showing an association between testosterone therapy and an increased risk in myocardial infarction, stroke and death, the FDA decided to re-evaluate the safety of this line of products. The FDA has taken steps to have the manufactures strengthen the label but continues to evaluate the information from these studies and other available data.
Heart attack and blood clots risks have been highlighted by studies cited by the FDA. The overall benefits of Low T therapy is unknown, and the risks may outweigh the benefits. Doctors have a duty to properly warn patients of the risks before any decision is made.
While testosterone therapy may seem like a great idea for many men, the treatment may only be right for some. Speak frankly with your doctor about the risks and benefits. If you are taking testosterone treatments, make sure your doctor is monitoring your health with regular blood tests.
Every year, hundreds of new drugs and supplements are put to market with approval from the U.S. Food and Drug Administration (FDA). However, some companies fail to properly test these products before they are prescribed by doctors and consumed by patients.
Some dangerous drugs end up causing serious side effects and complications that drug companies may or may not have known about, leading to warnings and product recalls. In either case, consumers are injured and pharmaceutical companies are liable for subsequent damages and injury. Testosterone therapy can be extremely helpful, or quite damaging, and several different patient reactions have been reported.
The popularity of testosterone replacement has had huge health implications for some injured patients. Rather than offer hormone replacement therapy to those with specific conditions, doctors have begun selling Low T treatments to many otherwise healthy, but aging, men.
If a healthy man has been treated with testosterone replacement therapy and has suffered a heart attack, blood clot, pulmonary embolism or other cardiac event, the manufacturer of the testosterone product and the prescribing physician may be liable for the damages.
Many Low T Clinics have touted their fountains of youth with testosterone replacement, and have hidden the risks behind success stories.
Heart attacks have been reported in men taking testosterone treatments, along with other side effects. Because a testosterone replacement will raise blood pressure, certain cardiac risks must be taken into account.
There is some contradicting information that may confuse patients. A study published in the journal The Aging Male found a link between low testosterone and heart problems. There has been no long-term studies, however, and much more research on testosterone and heart attacks is needed.
Some research suggests that both low testosterone and the testosterone therapy can cause cardiac problems. With that said, the FDA is still investigating testosterone heart health risks. All medication that contains testosterone must warn of an increased risk of heart attack and stroke.
Men are encouraged to speak with their doctors about the benefits and risks of testosterone replacement before starting any therapy. Men should also be aware of any symptoms of a heart attack, including:
Newer studies have concluded that with 3 months of beginning a course of testosterone therapy, there is an increased risks of venous thromboembolism (VTE). Patients and doctors are cautioned to consider other options or to closely monitor patients.
Testosterone therapy is associated with increased risk for venous thromboembolism (VTE), according to the recent study in JAMA Internal Medicine. Researchers identified around 40,000 men who had experienced a VTE, and testosterone therapy was more common in the 6 months before VTE compared with the control group.
There is an added risk of pulmonary embolism and blood clots following Low T treatments. Drug makers and doctors may have downplayed the risks, though they exist and injured patients may have malpractice claims.
Healthcare professionals and patients are encouraged to report adverse events or side effects related to the use of these products to the FDA’s MedWatch Safety Information and Adverse Event Reporting Program:
Joe Lyon is a highly-rated Cincinnati recall lawyer and Ohio product liability attorney investigating testosterone therapy injury lawsuits for plaintiffs nationwide. If you or someone you know is suffering due to the use of testosterone therapies, please contact the Lyon Firm at 800.513.2403 to learn about your legal options.
The Lyon Firm is dedicated to protecting the consumer in drug injury cases and testosterone therapy injury lawsuits. When drug companies fail to properly warn patients of the health risks of the product they produce and distribute, plaintiffs can file product liability lawsuits and recover rightful compensation.